PDC and limb ischemia: On the other hand, pharmacologic strategies to induce HIF stabilization have recently been tested in patients thereby setting the stage to use PHD inhibitors to treat patients suffering from diseases, such as chronic kidney disease and limb ischemia where the hyporesponsiveness of the HIF pathway has been observed [270].